COSMOS Pharmaceutical Corporation
CSMYF · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Market Cap | $3,650,590 | $524,193,713 | $549,809,815 | $466,307,379 |
| - Cash | $336,809 | $57,038,000 | $22,765,000 | $39,129,000 |
| + Debt | $282,471 | $49,957,000 | $28,529,000 | $25,675,000 |
| Enterprise Value | $3,596,252 | $517,112,713 | $555,573,815 | $452,853,379 |
| Revenue | $1,852,007 | $259,122,000 | $246,332,000 | $244,095,000 |
| % Growth | -99.3% | 5.2% | 0.9% | – |
| Gross Profit | $388,733 | $54,073,000 | $53,134,000 | $51,511,000 |
| % Margin | 21% | 20.9% | 21.6% | 21.1% |
| EBITDA | $122,022 | $15,306,000 | $15,921,000 | $14,169,000 |
| % Margin | 6.6% | 5.9% | 6.5% | 5.8% |
| Net Income | $55,555 | $8,635,000 | $7,915,000 | $6,285,000 |
| % Margin | 3% | 3.3% | 3.2% | 2.6% |
| EPS Diluted | 0.7 | 108.95 | 99.86 | 79.3 |
| % Growth | -99.4% | 9.1% | 25.9% | – |
| Operating Cash Flow | – | $0 | $0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $0 | $0 | $0 |